These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16860023)

  • 1. Procedural results and outcomes after extensive stent coverage with drug-eluting stent implantation in single coronary lesions.
    Mishra S; Wolfram RM; Torguson R; Xue Z; Gevorkian N; Chu WW; Satler LF; Pichard AD; Suddath WO; Kent KM; Waksman R
    Am J Cardiol; 2006 Aug; 98(3):357-61. PubMed ID: 16860023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions.
    Cosgrave J; Agostoni P; Ge L; Iakovou I; Chieffo A; Biondi-Zoccai GG; Sangiorgi GM; Montorfano M; Michev I; Airoldi F; Carlino M; Corvaja N; Bonizzoni E; Colombo A
    Am J Cardiol; 2005 Dec; 96(12):1663-8. PubMed ID: 16360354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous kissing drug-eluting stent technique for percutaneous treatment of bifurcation lesions in large-size vessels.
    Sharma SK
    Catheter Cardiovasc Interv; 2005 May; 65(1):10-6. PubMed ID: 15810018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study).
    Maresta A; Varani E; Balducelli M; Varbella F; Lettieri C; Uguccioni L; Sangiorgio P; Zoccai GB;
    Am J Cardiol; 2008 Jun; 101(11):1560-6. PubMed ID: 18489933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
    Kim YH; Dangas GD; Solinas E; Aoki J; Parise H; Kimura M; Franklin-Bond T; Dasgupta NK; Kirtane AJ; Moussa I; Lansky AJ; Collins M; Stone GW; Leon MB; Moses JW; Mehran R
    Am J Cardiol; 2008 Mar; 101(6):801-6. PubMed ID: 18328844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts.
    Lee MS; Shah AP; Aragon J; Jamali A; Dohad S; Kar S; Makkar RR
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):507-11. PubMed ID: 16270361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A; Cosgrave J; Latib A; Colombo A
    Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: comparison with bare-metal stent implantation.
    Gao RL; Xu B; Chen JL; Yang YJ; Qiao SB; Li JJ; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J
    Am Heart J; 2008 Mar; 155(3):553-61. PubMed ID: 18294496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained increased risk of adverse cardiac events over 5 years after implantation of gold-coated coronary stents.
    Pache J; Dibra A; Schaut C; Schühlen H; Dirschinger J; Mehilli J; Kastrati A; Schömig A
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):690-5. PubMed ID: 17039510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term (8 year) outcomes and predictors of major adverse cardiac events after full metal jacket drug-eluting stent implantation.
    Lee CW; Ahn JM; Lee JY; Kim WJ; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ;
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):361-5. PubMed ID: 24150889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
    JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results and predictors of angiographic restenosis and long-term adverse cardiac events after drug-eluting stent implantation for aorto-ostial coronary artery disease.
    Park DW; Hong MK; Suh IW; Hwang ES; Lee SW; Jeong YH; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2007 Mar; 99(6):760-5. PubMed ID: 17350360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late (3 years) follow-up of successful versus unsuccessful revascularization in chronic total coronary occlusions treated by drug eluting stent.
    Niccoli G; De Felice F; Belloni F; Fiorilli R; Cosentino N; Fracassi F; Cataneo L; Burzotta F; Trani C; Porto I; Leone AM; Musto C; Violini R; Crea F
    Am J Cardiol; 2012 Oct; 110(7):948-53. PubMed ID: 22721573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does creatine kinase-MB (CK-MB) isoenzyme elevation following percutaneous coronary intervention with drug-eluting stents impact late clinical outcome?
    Javaid A; Buch AN; Steinberg DH; Pinto Slottow T; Roy P; Pichard AD; Satler LF; Kent KM; Gevorkian N; Xue Z; Suddath WO; Waksman R
    Catheter Cardiovasc Interv; 2007 Nov; 70(6):826-31. PubMed ID: 17621656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of sirolimus-eluting and Paclitaxel-eluting stents on outcome in patients with diabetes mellitus and stenting in more than one coronary artery.
    Stankovic G; Cosgrave J; Chieffo A; Iakovou I; Sangiorgi G; Montorfano M; Airoldi F; Carlino M; Michev I; Finci L; Colombo A
    Am J Cardiol; 2006 Aug; 98(3):362-6. PubMed ID: 16860024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: results of a multicenter registry.
    Sanmartin M; Baz JA; Lozano I; de la Torre JM; Hernandez JM; Bordes P; Mainar V; Mauri J; Iñiguez A
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):372-7. PubMed ID: 17195194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
    Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
    Almalla M; Schröder J; Pross V; Marx N; Hoffmann R
    Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.